Latest News

Geojit recommended Reduce rating on Thermax with a target price of Rs 1911 in its research report dated November 18, 2022. Read More Top 100 Best Sellers

As the world descends on Qatar for the 2022 FIFA World Cup, many young players will shine brighter than others on the grandest stage. Read More Top 100 Best Sellers

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 17, 2022. Read More Top 100 Best Sellers

Realtors say rents for residential accommodation around the central business district is increasing radically, pushing up demand and lease rates in areas relatively farther from the city centre. The recurrent instances of flooding too is redrawing the city’s real estate… Read More »Bengaluru tenants witness up to 45% rent surge, even in areas once considered dormitory suburbs

The approval granted by the US Food Drug Administration (USFDA) to Strides Pharma Global Pte Ltd, Singapore, is for potassium chloride oral solution of strength 40 mEq/15mL (20 per cent), Strides Pharma Science (Strides) said in a regulatory filing. Read… Read More »Strides Pharma arms gets USFDA approval for potassium-deficiency drug

The EU proposal would be to set up a special fund for covering loss and damage in the most vulnerable countries – but funded from a “broad donor base”. Read More Top 100 Best Sellers

The company had clocked a revenue of close to Rs 4,000 crore during FY#39;22. Read More Top 100 Best Sellers

SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection. Read More Top 100 Best Sellers

The US Food and Drug Administration (USFDA) had conducted a pre-approval inspection of the facility from November 14, 2022, to November 17, 2022, Bajaj Healthcare Ltd (BHL) said in a regulatory filing. Read More Top 100 Best Sellers

Brazil, one of the app#39;s biggest markets, will be the first country to see the new tools deployed outside pilot programmes. Top 100 Best Sellers Read More